FP7HORIZONH2020
Deutsches Herzzentrum Munchen
- Country
- DEGermany
- Defence projects
- 0
- Projects, all programmes
- 13
- As coordinator
- 5
- EU contribution (CORDIS)
- EUR 8,237,813
- Active
- 2008 to 2025
Projects
13 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| EuroHeartPathEuroHeartPath: Leading Innovation in Cardiovascular Pathways for Improved Patient Outcomes | HORIZON | 2025 | Participant | EUR 525,406 |
| MATRICARDThe extracellular matrix as a mediator of cell-cell communication in cardiovascular inflammation | HORIZON | 2023 | Coordinator | EUR 1,495,750 |
| ArtPlacArtificial Placenta (ArtPlac) - Miniaturized Integrated Lung and Kidney Support for Critically Ill Newborns | HORIZON | 2023 | Participant | EUR 206,719 |
| MIRACLEMultiomIcs based Risk stratification of Atherosclerotic CardiovascuLar disEase | HORIZON | 2023 | Participant | EUR 590,625 |
| WCT EVI MAPMapping the Evidence for the WHO Classification of Tumours: a Living Evidence Gap Map by Tumour Type. | HORIZON | 2022 | Participant | EUR 649,812 |
| BEAT AFGround-BrEAking Electroporation-based inTervention for Atrial Fibrillation treatment (BEAT AF) | H2020 | 2021 | Participant | EUR 245,750 |
| STRATOStress as a modifier of atherosclerosis - Novel mechanistic insights and therapeutic avenues - | H2020 | 2018 | Coordinator | EUR 1,477,680 |
| EURO SHOCKTesting the value of a novel strategic approach and its cost efficacy to improve the poor outcomes in Cardiogenic Shock | H2020 | 2018 | Participant | EUR 252,500 |
| CVGENES-AT-TARGETExploitation of genomic variants affecting coronary artery disease and stroke risk for therapeutic intervention | FP7 | 2013 | Coordinator | EUR 853,354 |
| EPOCANGaining sage on the Epoetins' saga: assessing long term risks and advancing towards better Epoetin driven treatment modalities | FP7 | 2011 | Participant | EUR 180,520 |
| PRESTIGEPREvention of Late Stent Thrombosis by an Interdisciplinary Global European effort | FP7 | 2010 | Coordinator | EUR 1,182,400 |
| METOXIAMetastatic tumours facilitated by hypoxic tumour micro-environments | FP7 | 2009 | Participant | EUR 427,300 |
| MRI + ABLATIONMagnetic Resonance Guidance of Catheter Based Ablation for Cardiac Arrhythmia | FP7 | 2008 | Coordinator | EUR 149,997 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.